On Mar 2, 2022 Epsilogen closed a Series B round and raised £30,750,000 from 3B Future Health Fund, ALSA Ventures, British Patient Capital, Caribou Property, Epidarex Capital, Novartis Venture Fund, Schroders Capital, featuring lead investors Novartis Venture Fund.
About the company: Epsilogen is located at United Kingdom, Europe.
“”
Company website: http://www.epsilogen.com